Europe Agentic AI In Pharmaceuticals Market Size, Share & Industry Analysis Report By End User (Large Pharmaceutical Companies, and Small and Mid-Size Biotech Firms), By Deployment Mode (Cloud-Based, and Hybrid), By Application (Clinical-Trial Design and Recruitment, and Drug Discovery and Lead Identification), By Country Outlook and Forecast, 2026 - 2033

The Europe Agentic AI In Pharmaceuticals Market is expected to reach USD 316.29 million by 2031, growing at a CAGR of 36.8% during 2026 - 2033.

The Germany market dominated the Europe Agentic AI In Pharmaceuticals Market by Country in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 58.86 million by 2031, growing at a CAGR of 35% during the forecast period.

The Europe Agentic AI in Pharmaceuticals Market has evolved significantly with the growing adoption of autonomous artificial intelligence technologies across pharmaceutical research, drug development, regulatory compliance, and manufacturing operations. Initially, AI applications in the region focused on predictive analytics and data processing; however, advancements in machine learning, natural language processing, and autonomous reasoning capabilities have enabled the emergence of agentic AI systems capable of independently executing complex pharmaceutical workflows. The market is benefiting from strong pharmaceutical innovation ecosystems, increasing investments in digital transformation, and supportive regulatory frameworks encouraging responsible AI adoption across Europe.

Several trends are shaping the market. The increasing focus on explainable and trustworthy AI under the EU AI Act is driving pharmaceutical companies to adopt compliant agentic AI platforms. In addition, growing demand for accelerated drug discovery, optimized clinical trials, intelligent regulatory management, and advanced pharmaceutical data analytics is supporting wider adoption. The emergence of sovereign cloud infrastructure and secure AI ecosystems is further enabling pharmaceutical organizations to deploy agentic AI technologies while maintaining compliance with European data governance requirements.

End User Outlook

Based on End User, the market is segmented into Large Pharmaceutical Companies, Small and Mid-Size Biotech Firms, Contract Research Organizations, and Academic and Research Institutes.

The Large Pharmaceutical Companies market dominated the Europe Agentic AI In Pharmaceuticals Market by End User in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 165.07 million by 2031, growing at a CAGR of 36.2% during the forecast period. The Small and Mid-Size Biotech Firms market is expected to witness a CAGR of 36.1% during (2026 - 2033).

The Large Pharmaceutical Companies segment accounted for the largest revenue share in 2025 owing to increasing investments in AI-driven drug discovery, clinical development optimization, and pharmaceutical automation initiatives. The Small and Mid-Size Biotech Firms segment witnessed substantial growth supported by increasing adoption of cloud-based AI research platforms and growing biotechnology innovation activities. The Contract Research Organizations segment benefited from rising demand for outsourced clinical research services and AI-powered trial management solutions. The Academic and Research Institutes segment continued expanding through increasing utilization of advanced AI systems for biomedical research and pharmaceutical innovation.

Deployment Mode Outlook

Based on Deployment Mode, the market is segmented into Cloud-Based, Hybrid, and On-Premise.

The Cloud-Based segment dominated the market in 2025 owing to growing demand for scalable computing infrastructure, collaborative research environments, and cost-effective AI deployment models. The Hybrid segment recorded significant growth due to increasing demand for flexible deployment models balancing cloud scalability with enhanced data security and compliance requirements. The On-Premise segment maintained a notable market share among pharmaceutical organizations prioritizing direct control over sensitive research information, intellectual property, and regulatory compliance processes.

Application Outlook

Based on Application, the market is segmented into Clinical-Trial Design and Recruitment, Drug Discovery and Lead Identification, Lead Optimization, Pharmacovigilance and Safety Monitoring, Pre-clinical Development, Manufacturing-Process Optimization, and Other Applications.

The Clinical-Trial Design and Recruitment segment garnered the highest revenue share in 2025 owing to increasing use of AI-powered patient recruitment, protocol optimization, and decentralized clinical trial management solutions. The Drug Discovery and Lead Identification segment recorded strong growth driven by rising deployment of AI-powered molecular analysis and predictive research platforms.

The Lead Optimization segment benefited from increasing adoption of AI-driven simulation and candidate refinement technologies. The Pharmacovigilance and Safety Monitoring segment expanded due to growing demand for automated adverse event monitoring and regulatory reporting systems.

Free Valuable Insights: The Worldwide Agentic AI in Pharmaceuticals Market is projected to reach USD 2,418.1 Million billion by 2033, at a CAGR of 37.3%

Country Outlook

Based on Country, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The Germany and UK led the Europe Agentic AI In Pharmaceuticals Market by Country with a market share of 20.1% and 17.7% in 2025.The France market is expected to witness a CAGR of 37.7% during throughout the forecast period.

Germany dominated the Europe Agentic AI in Pharmaceuticals Market in 2025 owing to its strong pharmaceutical manufacturing base, advanced healthcare infrastructure, and increasing deployment of AI-enabled pharmaceutical innovation platforms. The UK is witnessing significant growth supported by expanding AI research ecosystems, strong biotechnology activity, and increasing adoption of agentic AI across clinical development processes. France continues to strengthen its market position through growing investments in pharmaceutical digitalization and AI-powered healthcare innovation.

List of Key Companies Profiled

• InSilico Medicine
• Numerion Labs, Inc.
• BenevolentAI Group
• Shenzhen Jingtai Technology Co., Ltd. (XtalPi)
• Recursion Pharmaceuticals, Inc.
• Deep Genomics Incorporated
• Schrödinger, LLC
• Owkin Inc.
• PeptiDream Inc.
• Healx Limited

Europe Agentic AI In Pharmaceuticals Market Report Segmentation

By End User

• Large Pharmaceutical Companies
• Small and Mid-Size Biotech Firms
• Contract Research Organizations
• Academic and Research Institutes

By Deployment Mode

• Cloud-Based
• Hybrid
• On-Premise

By Application

• Clinical-Trial Design and Recruitment
• Drug Discovery and Lead Identification
• Lead Optimization
• Pharmacovigilance and Safety Monitoring
• Pre-clinical Development
• Manufacturing-Process Optimization
• Other Application

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Europe Market
1.1 Market Overview
1.2 Key Factors Impacting Market
1.2.1 Market Drivers
1.2.2 Market Restraints
1.2.3 Market Opportunities
1.2.4 Market Challenges
1.2.5 Market Trends
1.2.6 State of Competition
1.2.7 Market Consolidation
1.2.8 Key Customer Criteria
1.3 Product Life Cycle
1.4 Segmentation By End User
1.4.1 Large Pharmaceutical Companies
1.4.2 Small and Mid-Size Biotech Firms
1.4.3 Contract Research Organizations
1.4.4 Academic and Research Institutes
1.5 Segmentation By Deployment Mode
1.5.1 Cloud-Based
1.5.2 Hybrid
1.5.3 On-Premise
1.6 Segmentation By Application
1.6.1 Clinical-Trial Design and Recruitment
1.6.2 Drug Discovery and Lead Identification
1.6.3 Lead Optimization
1.6.4 Pharmacovigilance and Safety Monitoring
1.6.5 Pre-clinical Development
1.6.6 Manufacturing-Process Optimization
1.6.7 Other Application
1.7 Segmentation By Country
1.7.1 Germany
1.7.1.1 Segmentation By End User
1.7.1.1.1 Large Pharmaceutical Companies
1.7.1.1.2 Small and Mid-Size Biotech Firms
1.7.1.1.3 Contract Research Organizations
1.7.1.1.4 Academic and Research Institutes
1.7.1.2 Segmentation By Deployment Mode
1.7.1.2.1 Cloud-Based
1.7.1.2.2 Hybrid
1.7.1.2.3 On-Premise
1.7.1.3 Segmentation By Application
1.7.1.3.1 Clinical-Trial Design and Recruitment
1.7.1.3.2 Drug Discovery and Lead Identification
1.7.1.3.3 Lead Optimization
1.7.1.3.4 Pharmacovigilance and Safety Monitoring
1.7.1.3.5 Pre-clinical Development
1.7.1.3.6 Manufacturing-Process Optimization
1.7.1.3.7 Other Application
1.7.2 UK
1.7.2.1 Segmentation By End User
1.7.2.1.1 Large Pharmaceutical Companies
1.7.2.1.2 Small and Mid-Size Biotech Firms
1.7.2.1.3 Contract Research Organizations
1.7.2.1.4 Academic and Research Institutes
1.7.2.2 Segmentation By Deployment Mode
1.7.2.2.1 Cloud-Based
1.7.2.2.2 Hybrid
1.7.2.2.3 On-Premise
1.7.2.3 Segmentation By Application
1.7.2.3.1 Clinical-Trial Design and Recruitment
1.7.2.3.2 Drug Discovery and Lead Identification
1.7.2.3.3 Lead Optimization
1.7.2.3.4 Pharmacovigilance and Safety Monitoring
1.7.2.3.5 Pre-clinical Development
1.7.2.3.6 Manufacturing-Process Optimization
1.7.2.3.7 Other Application
1.7.3 France
1.7.3.1 Segmentation By End User
1.7.3.1.1 Large Pharmaceutical Companies
1.7.3.1.2 Small and Mid-Size Biotech Firms
1.7.3.1.3 Contract Research Organizations
1.7.3.1.4 Academic and Research Institutes
1.7.3.2 Segmentation By Deployment Mode
1.7.3.2.1 Cloud-Based
1.7.3.2.2 Hybrid
1.7.3.2.3 On-Premise
1.7.3.3 Segmentation By Application
1.7.3.3.1 Clinical-Trial Design and Recruitment
1.7.3.3.2 Drug Discovery and Lead Identification
1.7.3.3.3 Lead Optimization
1.7.3.3.4 Pharmacovigilance and Safety Monitoring
1.7.3.3.5 Pre-clinical Development
1.7.3.3.6 Manufacturing-Process Optimization
1.7.3.3.7 Other Application
1.7.4 Russia
1.7.4.1 Segmentation By End User
1.7.4.1.1 Large Pharmaceutical Companies
1.7.4.1.2 Small and Mid-Size Biotech Firms
1.7.4.1.3 Contract Research Organizations
1.7.4.1.4 Academic and Research Institutes
1.7.4.2 Segmentation By Deployment Mode
1.7.4.2.1 Cloud-Based
1.7.4.2.2 Hybrid
1.7.4.2.3 On-Premise
1.7.4.3 Segmentation By Application
1.7.4.3.1 Clinical-Trial Design and Recruitment
1.7.4.3.2 Drug Discovery and Lead Identification
1.7.4.3.3 Lead Optimization
1.7.4.3.4 Pharmacovigilance and Safety Monitoring
1.7.4.3.5 Pre-clinical Development
1.7.4.3.6 Manufacturing-Process Optimization
1.7.4.3.7 Other Application
1.7.5 Spain
1.7.5.1 Segmentation By End User
1.7.5.1.1 Large Pharmaceutical Companies
1.7.5.1.2 Small and Mid-Size Biotech Firms
1.7.5.1.3 Contract Research Organizations
1.7.5.1.4 Academic and Research Institutes
1.7.5.2 Segmentation By Deployment Mode
1.7.5.2.1 Cloud-Based
1.7.5.2.2 Hybrid
1.7.5.2.3 On-Premise
1.7.5.3 Segmentation By Application
1.7.5.3.1 Clinical-Trial Design and Recruitment
1.7.5.3.2 Drug Discovery and Lead Identification
1.7.5.3.3 Lead Optimization
1.7.5.3.4 Pharmacovigilance and Safety Monitoring
1.7.5.3.5 Pre-clinical Development
1.7.5.3.6 Manufacturing-Process Optimization
1.7.5.3.7 Other Application
1.7.6 Italy
1.7.6.1 Segmentation By End User
1.7.6.1.1 Large Pharmaceutical Companies
1.7.6.1.2 Small and Mid-Size Biotech Firms
1.7.6.1.3 Contract Research Organizations
1.7.6.1.4 Academic and Research Institutes
1.7.6.2 Segmentation By Deployment Mode
1.7.6.2.1 Cloud-Based
1.7.6.2.2 Hybrid
1.7.6.2.3 On-Premise
1.7.6.3 Segmentation By Application
1.7.6.3.1 Clinical-Trial Design and Recruitment
1.7.6.3.2 Drug Discovery and Lead Identification
1.7.6.3.3 Lead Optimization
1.7.6.3.4 Pharmacovigilance and Safety Monitoring
1.7.6.3.5 Pre-clinical Development
1.7.6.3.6 Manufacturing-Process Optimization
1.7.6.3.7 Other Application
1.7.7 Rest of Europe
1.7.7.1 Segmentation By End User
1.7.7.1.1 Large Pharmaceutical Companies
1.7.7.1.2 Small and Mid-Size Biotech Firms
1.7.7.1.3 Contract Research Organizations
1.7.7.1.4 Academic and Research Institutes
1.7.7.2 Segmentation By Deployment Mode
1.7.7.2.1 Cloud-Based
1.7.7.2.2 Hybrid
1.7.7.2.3 On-Premise
1.7.7.3 Segmentation By Application
1.7.7.3.1 Clinical-Trial Design and Recruitment
1.7.7.3.2 Drug Discovery and Lead Identification
1.7.7.3.3 Lead Optimization
1.7.7.3.4 Pharmacovigilance and Safety Monitoring
1.7.7.3.5 Pre-clinical Development
1.7.7.3.6 Manufacturing-Process Optimization
1.7.7.3.7 Other Application


Chapter 2. Company Snapshot
2.1 InSilico Medicine
2.1.1 Business Overview
2.1.2 Key Information
2.1.3 Company Focus
2.1.4 Strategic Insights
2.1.5 Strategy Deployed
2.1.6 Product & Service Portfolio
2.1.7 Capability Overview
2.1.8 Technology & Innovation Focus
2.1.9 Customers / End Users
2.1.10 Competitive Positioning
2.1.11 Key Differentiators
2.1.12 Portfolio Matrix
2.1.13 SWOT Analysis
2.1.14 Future Outlook
2.2 Numerion Labs, Inc.
2.2.1 Business Overview
2.2.2 Key Information
2.2.3 Company Focus
2.2.4 Strategic Insights
2.2.5 Strategy Deployed
2.2.6 Product & Service Portfolio
2.2.7 Capability Overview
2.2.8 Technology & Innovation Focus
2.2.9 Customers / End Users
2.2.10 Competitive Positioning
2.2.11 Key Differentiators
2.2.12 Portfolio Matrix
2.2.13 SWOT Analysis
2.2.14 Future Outlook
2.3 BenevolentAI Group
2.3.1 Business Overview
2.3.2 Key Information
2.3.3 Company Focus
2.3.4 Strategic Insights
2.3.5 Strategy Deployed
2.3.6 Product & Service Portfolio
2.3.7 Capability Overview
2.3.8 Technology & Innovation Focus
2.3.9 Customers / End Users
2.3.10 Competitive Positioning
2.3.11 Key Differentiators
2.3.12 Portfolio Matrix
2.3.13 SWOT Analysis
2.3.14 Future Outlook
2.4 Shenzhen Jingtai Technology Co., Ltd (XtalPi)
2.4.1 Business Overview
2.4.2 Key Information
2.4.3 Company Focus
2.4.4 Strategic Insights
2.4.5 Strategy Deployed
2.4.6 Product & Service Portfolio
2.4.7 Capability Overview
2.4.8 Technology & Innovation Focus
2.4.9 Customers / End Users
2.4.10 Competitive Positioning
2.4.11 Key Differentiators
2.4.12 Portfolio Matrix
2.4.13 SWOT Analysis
2.4.14 Future Outlook
2.5 Recursion Pharmaceuticals, Inc.
2.5.1 Business Overview
2.5.2 Key Information
2.5.3 Company Focus
2.5.4 Strategic Insights
2.5.5 Strategy Deployed
2.5.6 Product & Service Portfolio
2.5.7 Capability Overview
2.5.8 Technology & Innovation Focus
2.5.9 Customers / End Users
2.5.10 Competitive Positioning
2.5.11 Key Differentiators
2.5.12 Portfolio Matrix
2.5.13 SWOT Analysis
2.5.14 Future Outlook
2.6 Deep Genomics Incorporated
2.6.1 Business Overview
2.6.2 Key Information
2.6.3 Company Focus
2.6.4 Strategic Insights
2.6.5 Strategy Deployed
2.6.6 Product & Service Portfolio
2.6.7 Capability Overview
2.6.8 Technology & Innovation Focus
2.6.9 Customers / End Users
2.6.10 Competitive Positioning
2.6.11 Key Differentiators 2.6.12 Portfolio Matrix
2.6.13 SWOT Analysis
2.6.14 Future Outlook
2.7 Schrödinger, LLC
2.7.1 Business Overview
2.7.2 Key Information
2.7.3 Company Focus
2.7.4 Strategic Insights
2.7.5 Strategy Deployed
2.7.6 Product & Service Portfolio
2.7.7 Capability Overview
2.7.8 Technology & Innovation Focus
2.7.9 Customers / End Users
2.7.10 Competitive Positioning
2.7.11 Key Differentiators
2.7.12 Portfolio Matrix
2.7.13 SWOT Analysis
2.7.14 Future Outlook
2.8 Owkin Inc.
2.8.1 Business Overview
2.8.2 Key Information
2.8.3 Company Focus
2.8.4 Strategic Insights
2.8.5 Strategy Deployed
2.8.6 Product & Service Portfolio
2.8.7 Capability Overview
2.8.8 Technology & Innovation Focus
2.8.9 Customers / End Users
2.8.10 Competitive Positioning
2.8.11 Key Differentiators
2.8.12 Portfolio Matrix
2.8.13 SWOT Analysis
2.8.14 Future Outlook
2.9 PeptiDream Inc.
2.9.1 Business Overview
2.9.2 Key Information
2.9.3 Company Focus
2.9.4 Strategic Insights
2.9.5 Strategy Deployed
2.9.6 Product & Service Portfolio
2.9.7 Capability Overview
2.9.8 Technology & Innovation Focus
2.9.9 Customers / End Users
2.9.10 Competitive Positioning
2.9.11 Key Differentiators
2.9.12 Portfolio Matrix
2.9.13 SWOT Analysis
2.9.14 Future Outlook
2.10 Healx Limited
2.10.1 Business Overview
2.10.2 Key Information
2.10.3 Company Focus
2.10.4 Strategic Insights
2.10.5 Strategy Deployed
2.10.6 Product & Service Portfolio
2.10.7 Capability Overview
2.10.8 Technology & Innovation Focus
2.10.9 Customers / End Users
2.10.10 Competitive Positioning
2.10.11 Key Differentiators
2.10.12 Portfolio Matrix
2.10.13 SWOT Analysis
2.10.14 Future Outlook

List of Tables
TABLE 1 Europe Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 2 Methodology for the research
TABLE 3 Key Factors Impacting Market
TABLE 4 Market Consolidation
TABLE 5 Key Customer Criteria
TABLE 6 Product Life Cycle
TABLE 7 Europe Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 8 Europe Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 9 Europe Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 10 Europe Lead Optimization Market, 2022 - 2033, USD Million
TABLE 11 Europe Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 12 Europe Other Application Market, 2022 - 2033, USD Million
TABLE 13 Europe Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 14 Europe Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 15 Europe Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 16 Europe Cloud-Based Market, 2022 - 2033, USD Million
TABLE 17 Europe Hybrid Market, 2022 - 2033, USD Million
TABLE 18 Europe On-Premise Market, 2022 - 2033, USD Million
TABLE 19 Europe Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 20 Europe Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 21 Europe Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 22 Europe Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 23 Europe Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
TABLE 24 France Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 25 Methodology for the research
TABLE 26 Key Factors Impacting Market
TABLE 27 Market Consolidation
TABLE 28 Key Customer Criteria
TABLE 29 Product Life Cycle
TABLE 30 France Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 31 France Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 32 France Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 33 France Lead Optimization Market, 2022 - 2033, USD Million
TABLE 34 France Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 35 France Other Application Market, 2022 - 2033, USD Million
TABLE 36 France Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 37 France Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 38 France Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 39 France Cloud-Based Market, 2022 - 2033, USD Million
TABLE 40 France Hybrid Market, 2022 - 2033, USD Million
TABLE 41 France On-Premise Market, 2022 - 2033, USD Million
TABLE 42 France Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 43 France Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 44 France Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 45 France Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 46 France Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
TABLE 47 Germany Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 48 Methodology for the research
TABLE 49 Key Factors Impacting Market
TABLE 50 Market Consolidation
TABLE 51 Key Customer Criteria
TABLE 52 Product Life Cycle
TABLE 53 Germany Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 54 Germany Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 55 Germany Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 56 Germany Lead Optimization Market, 2022 - 2033, USD Million
TABLE 57 Germany Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 58 Germany Other Application Market, 2022 - 2033, USD Million
TABLE 59 Germany Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 60 Germany Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 61 Germany Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 62 Germany Cloud-Based Market, 2022 - 2033, USD Million
TABLE 63 Germany Hybrid Market, 2022 - 2033, USD Million
TABLE 64 Germany On-Premise Market, 2022 - 2033, USD Million
TABLE 65 Germany Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 66 Germany Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 67 Germany Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 68 Germany Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 69 Germany Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
TABLE 70 Italy Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 71 Methodology for the research
TABLE 72 Key Factors Impacting Market
TABLE 73 Market Consolidation
TABLE 74 Key Customer Criteria
TABLE 75 Product Life Cycle
TABLE 76 Italy Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 77 Italy Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 78 Italy Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 79 Italy Lead Optimization Market, 2022 - 2033, USD Million
TABLE 80 Italy Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 81 Italy Other Application Market, 2022 - 2033, USD Million
TABLE 82 Italy Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 83 Italy Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 84 Italy Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 85 Italy Cloud-Based Market, 2022 - 2033, USD Million
TABLE 86 Italy Hybrid Market, 2022 - 2033, USD Million
TABLE 87 Italy On-Premise Market, 2022 - 2033, USD Million
TABLE 88 Italy Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 89 Italy Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 90 Italy Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 91 Italy Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 92 Italy Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
TABLE 93 Russia Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 94 Methodology for the research
TABLE 95 Key Factors Impacting Market
TABLE 96 Market Consolidation
TABLE 97 Key Customer Criteria
TABLE 98 Product Life Cycle
TABLE 99 Russia Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 100 Russia Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 101 Russia Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 102 Russia Lead Optimization Market, 2022 - 2033, USD Million
TABLE 103 Russia Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 104 Russia Other Application Market, 2022 - 2033, USD Million
TABLE 105 Russia Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 106 Russia Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 107 Russia Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 108 Russia Cloud-Based Market, 2022 - 2033, USD Million
TABLE 109 Russia Hybrid Market, 2022 - 2033, USD Million
TABLE 110 Russia On-Premise Market, 2022 - 2033, USD Million
TABLE 111 Russia Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 112 Russia Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 113 Russia Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 114 Russia Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 115 Russia Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
TABLE 116 Spain Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 117 Methodology for the research
TABLE 118 Key Factors Impacting Market
TABLE 119 Market Consolidation
TABLE 120 Key Customer Criteria
TABLE 121 Product Life Cycle
TABLE 122 Spain Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 123 Spain Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 124 Spain Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 125 Spain Lead Optimization Market, 2022 - 2033, USD Million
TABLE 126 Spain Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 127 Spain Other Application Market, 2022 - 2033, USD Million
TABLE 128 Spain Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 129 Spain Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 130 Spain Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 131 Spain Cloud-Based Market, 2022 - 2033, USD Million
TABLE 132 Spain Hybrid Market, 2022 - 2033, USD Million
TABLE 133 Spain On-Premise Market, 2022 - 2033, USD Million
TABLE 134 Spain Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 135 Spain Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 136 Spain Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 137 Spain Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 138 Spain Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
TABLE 139 United Kingdom Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 140 Methodology for the research
TABLE 141 Key Factors Impacting Market
TABLE 142 Market Consolidation
TABLE 143 Key Customer Criteria
TABLE 144 Product Life Cycle
TABLE 145 United Kingdom Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 146 United Kingdom Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 147 United Kingdom Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 148 United Kingdom Lead Optimization Market, 2022 - 2033, USD Million
TABLE 149 United Kingdom Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 150 United Kingdom Other Application Market, 2022 - 2033, USD Million
TABLE 151 United Kingdom Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 152 United Kingdom Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 153 United Kingdom Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 154 United Kingdom Cloud-Based Market, 2022 - 2033, USD Million
TABLE 155 United Kingdom Hybrid Market, 2022 - 2033, USD Million
TABLE 156 United Kingdom On-Premise Market, 2022 - 2033, USD Million
TABLE 157 United Kingdom Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 158 United Kingdom Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 159 United Kingdom Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 160 United Kingdom Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 161 United Kingdom Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
TABLE 162 Rest of Europe Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 163 Methodology for the research
TABLE 164 Key Factors Impacting Market
TABLE 165 Market Consolidation
TABLE 166 Key Customer Criteria
TABLE 167 Product Life Cycle
TABLE 168 Rest of Europe Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 169 Rest of Europe Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 170 Rest of Europe Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 171 Rest of Europe Lead Optimization Market, 2022 - 2033, USD Million
TABLE 172 Rest of Europe Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 173 Rest of Europe Other Application Market, 2022 - 2033, USD Million
TABLE 174 Rest of Europe Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 175 Rest of Europe Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 176 Rest of Europe Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 177 Rest of Europe Cloud-Based Market, 2022 - 2033, USD Million
TABLE 178 Rest of Europe Hybrid Market, 2022 - 2033, USD Million
TABLE 179 Rest of Europe On-Premise Market, 2022 - 2033, USD Million
TABLE 180 Rest of Europe Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 181 Rest of Europe Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 182 Rest of Europe Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 183 Rest of Europe Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 184 Rest of Europe Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million


List of Figures
FIG 1 Methodology for the research
FIG 2 Key Factors Impacting Market
FIG 3 Market Consolidation
FIG 4 Key Customer Criteria
FIG 5 Product Life Cycle
FIG 6 Europe Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 7 Europe Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 8 Europe Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 9 Europe Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 10 Europe Lead Optimization Market, 2022 - 2033, USD Million
FIG 11 Europe Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 12 Europe Other Application Market, 2022 - 2033, USD Million
FIG 13 Europe Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 14 Europe Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 15 Europe Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 16 Europe Cloud-Based Market, 2022 - 2033, USD Million
FIG 17 Europe Hybrid Market, 2022 - 2033, USD Million
FIG 18 Europe On-Premise Market, 2022 - 2033, USD Million
FIG 19 Europe Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 20 Europe Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 21 Europe Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 22 Europe Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
FIG 23 Europe Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
FIG 24 France Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 25 France Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 26 France Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 27 France Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 28 France Lead Optimization Market, 2022 - 2033, USD Million
FIG 29 France Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 30 France Other Application Market, 2022 - 2033, USD Million
FIG 31 France Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 32 France Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 33 France Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 34 France Cloud-Based Market, 2022 - 2033, USD Million
FIG 35 France Hybrid Market, 2022 - 2033, USD Million
FIG 36 France On-Premise Market, 2022 - 2033, USD Million
FIG 37 France Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 38 France Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 39 France Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 40 France Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
FIG 41 France Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
FIG 42 Germany Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 43 Germany Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 44 Germany Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 45 Germany Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 46 Germany Lead Optimization Market, 2022 - 2033, USD Million
FIG 47 Germany Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 48 Germany Other Application Market, 2022 - 2033, USD Million
FIG 49 Germany Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 50 Germany Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 51 Germany Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 52 Germany Cloud-Based Market, 2022 - 2033, USD Million
FIG 53 Germany Hybrid Market, 2022 - 2033, USD Million
FIG 54 Germany On-Premise Market, 2022 - 2033, USD Million
FIG 55 Germany Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 56 Germany Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 57 Germany Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 58 Germany Large Pharmaceutical Companies Market, 2022 - 2033, USD Million FIG 59 Germany Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
FIG 60 Italy Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 61 Italy Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 62 Italy Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 63 Italy Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 64 Italy Lead Optimization Market, 2022 - 2033, USD Million
FIG 65 Italy Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 66 Italy Other Application Market, 2022 - 2033, USD Million
FIG 67 Italy Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 68 Italy Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 69 Italy Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 70 Italy Cloud-Based Market, 2022 - 2033, USD Million
FIG 71 Italy Hybrid Market, 2022 - 2033, USD Million
FIG 72 Italy On-Premise Market, 2022 - 2033, USD Million
FIG 73 Italy Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 74 Italy Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 75 Italy Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 76 Italy Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
FIG 77 Italy Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
FIG 78 Russia Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 79 Russia Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 80 Russia Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 81 Russia Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 82 Russia Lead Optimization Market, 2022 - 2033, USD Million
FIG 83 Russia Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 84 Russia Other Application Market, 2022 - 2033, USD Million
FIG 85 Russia Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 86 Russia Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 87 Russia Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 88 Russia Cloud-Based Market, 2022 - 2033, USD Million
FIG 89 Russia Hybrid Market, 2022 - 2033, USD Million
FIG 90 Russia On-Premise Market, 2022 - 2033, USD Million
FIG 91 Russia Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 92 Russia Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 93 Russia Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 94 Russia Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
FIG 95 Russia Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
FIG 96 Spain Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 97 Spain Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 98 Spain Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 99 Spain Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 100 Spain Lead Optimization Market, 2022 - 2033, USD Million
FIG 101 Spain Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 102 Spain Other Application Market, 2022 - 2033, USD Million
FIG 103 Spain Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 104 Spain Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 105 Spain Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 106 Spain Cloud-Based Market, 2022 - 2033, USD Million
FIG 107 Spain Hybrid Market, 2022 - 2033, USD Million
FIG 108 Spain On-Premise Market, 2022 - 2033, USD Million
FIG 109 Spain Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 110 Spain Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 111 Spain Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 112 Spain Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
FIG 113 Spain Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
FIG 114 United Kingdom Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 115 United Kingdom Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 116 United Kingdom Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 117 United Kingdom Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 118 United Kingdom Lead Optimization Market, 2022 - 2033, USD Million
FIG 119 United Kingdom Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 120 United Kingdom Other Application Market, 2022 - 2033, USD Million
FIG 121 United Kingdom Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 122 United Kingdom Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 123 United Kingdom Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 124 United Kingdom Cloud-Based Market, 2022 - 2033, USD Million
FIG 125 United Kingdom Hybrid Market, 2022 - 2033, USD Million
FIG 126 United Kingdom On-Premise Market, 2022 - 2033, USD Million
FIG 127 United Kingdom Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 128 United Kingdom Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 129 United Kingdom Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 130 United Kingdom Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
FIG 131 United Kingdom Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
FIG 132 Rest of Europe Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 133 Rest of Europe Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 134 Rest of Europe Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 135 Rest of Europe Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 136 Rest of Europe Lead Optimization Market, 2022 - 2033, USD Million
FIG 137 Rest of Europe Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 138 Rest of Europe Other Application Market, 2022 - 2033, USD Million
FIG 139 Rest of Europe Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 140 Rest of Europe Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 141 Rest of Europe Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 142 Rest of Europe Cloud-Based Market, 2022 - 2033, USD Million
FIG 143 Rest of Europe Hybrid Market, 2022 - 2033, USD Million
FIG 144 Rest of Europe On-Premise Market, 2022 - 2033, USD Million
FIG 145 Rest of Europe Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 146 Rest of Europe Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 147 Rest of Europe Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 148 Rest of Europe Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
FIG 149 Rest of Europe Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million